Atlas Trials

Importance of the Infusion Rate for the Plasma Expanding Effect of 5% Albumin in the Septic Patient

Clinical trial NCT03153306 · UNKNOWN

Trial details

NCT number
NCT03153306
Sponsor
Hainan People's Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Sepsis
Start date
2016-06-01
Primary completion
2017-12-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.